Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ASND US Equity

Ascendis Pharma A/SHealth Care · Pharmaceutical Preparations · CIK 1612042 · FY ends Dec 31
$259.62
+10.77 (+4.33%)
USD · as of 2026-08-19 · marketstack
0 8-K filings · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Artisan Partners Limited Partnershipsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-13

Every row is a filed document, checked against its EDGAR index.